RAPIDANTIBODY

Welcome to the Brand page for “RAPIDANTIBODY”, which is offered here for Diagnostic agents, preparations and substances for medical purposes; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, coronavirus, influenza a and b, sexually transmitted diseases, hiv, hepatitis, tb and other detectible antibodies.; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic reagents and contrast media for medical use; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of alcohol, amphetamines, barbiturates, benzodiazepines, methadone, cocaine, opiates, including codeine, oxycodone, and heroin, phencyclidine (pcp) and tetrahydrocannabinol (thc).; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents for the analysis of body fluids; medical diagnostic test media in the form of rapid result test strips for measuring qualitative and quantitative immunological and enzymatic assays; medical diagnostic test strips for use in the field of infectious diseases and chronic care management; medical diagnostic test strips for rapid result test strips for measuring qualitative and quantitative immunological and enzymatic assays;.

Its status is currently believed to be active. Its class is unavailable. “RAPIDANTIBODY” is believed to be currently owned by “Milo IP Holder LLC”.